Treatmentemerging

Prolotherapy

Injection of an irritant solution (usually hypertonic dextrose) into joints, ligaments, or tendons to trigger a localized healing response, marketed for chronic joint pain, ligament laxity, and 'regenerative' joint support.

Evidence

emerging

Systematic reviews show dextrose prolotherapy reduces pain and improves function in knee osteoarthritis, but trials are small and non-standardized, and there is no evidence for any systemic longevity benefit.

Regulatory notes

European Union
Uses approved dextrose solutions off-label as a physician-administered procedure; not a licensed longevity treatment and claims must stay within musculoskeletal scope.
United States
Not FDA-approved as a specific therapy; performed off-label with standard injectable dextrose and marketed at physician discretion.
United Arab Emirates
Offered by licensed practitioners as an orthopedic/pain procedure under DHA oversight; longevity claims are not endorsed.
United Kingdom
Available as an off-label physician-administered injection; no approved longevity indication.

General information, not medical or legal advice. See our disclaimer.

Also known as

prolotherapy, dextrose prolotherapy, hypertonic dextrose injection, regenerative injection therapy, RIT, proliferation therapy, sugar injection

Where to find it

75 clinics in the directory offer prolotherapy. Prices shown are the cheapest for this treatment where published; always confirm with the venue.

London

Back to glossary